EFS
TEVA icon

Essex Financial Services’s Teva Pharmaceuticals TEVA Stock Holding History

Essex Financial Services’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$486K Sell
16,147
-385
-2% -$12.4K 0.03% 466
2025
Q4 		$516K Sell
16,532
-41
-0.2% -$1.01K 0.03% 432
2025
Q3 		$335K Sell
16,573
-1
-0% -$18 0.02% 545
2025
Q2 		$278K Sell
16,574
-292
-2% -$4.71K 0.02% 574
2025
Q1 		$259K Sell
16,866
-102
-0.6% -$1.82K 0.02% 533
2024
Q4 		$374K Sell
16,968
-402
-2% -$7.31K 0.03% 438
2024
Q3 		$319K Buy
+17,370
New +$304K 0.02% 477

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Essex Financial Services's TEVA Position: Q1 2026 in Review

Essex Financial Services reduced its Teva Pharmaceuticals (TEVA) stake by 2.3% in Q1 2026, selling an estimated $12.4K and leaving 16,147 shares worth $486K. The position accounts for 0.03% of the portfolio, ranked #466.

Essex Financial Services first reported a position in TEVA in Q3 2024 and has held it in 7 quarters since. The position peaked at $516K in Q4 2025. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Essex Financial Services held 16,147 shares of Teva Pharmaceuticals worth $486K as of Q1 2026.
  • Essex Financial Services sold 385 Teva Pharmaceuticals shares in Q1 2026, an estimated $12.4K.
  • Teva Pharmaceuticals made up 0.03% of Essex Financial Services's portfolio in Q1 2026, its #466 holding.
  • Essex Financial Services first reported a position in Teva Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • Essex Financial Services's Teva Pharmaceuticals position peaked at $516K in Q4 2025.
  • 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Essex Financial Services's 13F filing for Q1 2026, filed 24 Apr 2026.